In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Three-Part Medtech Innovation Equation: The Thoracic Surgeon’s View

Executive Summary

Medtech advancements leading to cost savings and improved outcomes are the result of a confluence of three elements: technology, clinical processes, and the business case, according to consultant thoracic surgeon Aman Coonar.

You may also be interested in...



Intuitive’s da Vinci: Will Familiarity Breed Success?

Robotic soft-tissue MIS pioneer Intuitive Surgical continues to advance its offering in this disruptive area of medical technology. Having weathered an adverse incident-related storm, it is putting efforts into driving OUS business, broadening surgical applications, and convincing the doubters about robotic surgery’s place and role in the catalog of care delivery.

Right First Time: SME Innovator Winning The Argument Against Perverse Incentives

In championing Forte Medical’s precision diagnostics technology to improve the quality of urine test samples, 2022 Rising Leader Giovanna Forte has often had to confront market access hurdles. It has not dented her drive to secure widespread adoption of money-saving and outcomes-boosting devices.

Bernasconi: Europe Needs A Better Strategic Rudder For Medtech Innovation Policy

Always ready to frame the needs of EU medtechs clearly and succinctly, MedTech Europe CEO Serge Bernasconi says that the local industry in the future could benefit from more strategic direction and support from a dedicated EU agency or similar tighter governance structure.

Topics

Related Companies

UsernamePublicRestriction

Register

IV004366

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel